DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Virtual Event

2020年8月17日 (月) 午前 9:00 - 2020年8月17日 (月) 午後 12:30

(US Eastern Standard Time)

Horsham, PA 19044

Short Course 1: eCOA 101: The What, Why, and How of eCOA to Reduce Barriers to Adoption in Clinical Studies

Instructors

Paul  O'Donohoe, MS, MSc

Paul O'Donohoe, MS, MSc

Senior Director, eCOA Product and Science, Medidata Solutions, United States

Paul O’Donohoe is Senior Director, eCOA Product and Science at Medidata Solutions, a clinical software platform provider. He is responsible for providing strategic oversight of the development of Medidata's electronic clinical outcome assessment technologies, and supporting internal teams and partners around the implementation of industry, regulatory and scientific best practices in clinical trials using mobile health technologies. He is passionate about developing the field of eCOA and mobile health through research and active involvement in industry consortia, and is currently the Industry Vice-Director of the C-Path ePRO Consortium.

Katherine  Zarzar

Katherine Zarzar

Head of Agile Execution, Patient-Centered Outcomes Research, Genentech, A Member of the Roche Group, United States

Kate Zarzar is a Principal PCOR Scientist and Head of Agile Execution focused on designing and delivering COA strategies at Roche. As head of Agile Execution, she focuses on leveraging agile methodology to improve how the business executes paper COA and eCOA strategies to generate patient-relevant evidence. Prior to joining Roche eight years ago, Kate spent six years at TransPerfect leading the design and oversight of linguistic validation programs for a variety of sponsors. Kate specializes in global cross-functional and cross-industry partnerships to drive improvement in the development and implementation of COA strategies. Kate is passionate about enabling further understanding and insight into the patient experience.

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。